Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-044633
Filing Date
2025-03-25
Accepted
2025-03-25 18:32:00
Documents
1
Period of Report
2025-03-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 2896
  Complete submission text file 0000950170-25-044633.txt   4363
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address MONTE ROSA THERAPEUTICS, INC. 40 GUEST STREET BOSTON MA 02135
Business Address
Leo Chandra P. (Reporting) CIK: 0001855642 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40522 | Film No.: 25769619